494 related articles for article (PubMed ID: 11358199)
1. Neuroleptic malignant syndrome without neuroleptics.
Ong KC; Chew EL; Ong YY
Singapore Med J; 2001 Feb; 42(2):85-8. PubMed ID: 11358199
[TBL] [Abstract][Full Text] [Related]
2. Neuroleptic malignant syndrome without neuroleptics.
Parsa MA; Rohr T; Ramirez LF; Meltzer HY
J Clin Psychopharmacol; 1990 Dec; 10(6):437-8. PubMed ID: 2286714
[No Abstract] [Full Text] [Related]
3. Neuroleptic malignant syndrome in Parkinson's disease after withdrawal or alteration of dopaminergic therapy.
Keyser DL; Rodnitzky RL
Arch Intern Med; 1991 Apr; 151(4):794-6. PubMed ID: 1672810
[TBL] [Abstract][Full Text] [Related]
4. Neuroleptic malignant syndrome in a patient with Parkinson's disease: a case study.
Ward C
J Neurosci Nurs; 2005 Jun; 37(3):160-2. PubMed ID: 16001822
[TBL] [Abstract][Full Text] [Related]
5. A case of malignant syndrome associated with a parkinsonism patient.
Sanga M; Nomura S
Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Apr; 23(2):91-5. PubMed ID: 12762221
[TBL] [Abstract][Full Text] [Related]
6. Case of neuroleptic malignant-like syndrome precipitated by abrupt fava bean discontinuance.
Ladha SS; Walker R; Shill HA
Mov Disord; 2005 May; 20(5):630-1. PubMed ID: 15719433
[TBL] [Abstract][Full Text] [Related]
7. [Neuroleptic malignant syndrome. Case reports].
Berardi D; Troia M; Veronesi L; Ferrari G
Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
[TBL] [Abstract][Full Text] [Related]
8. An interaction between levodopa and enteral nutrition resulting in neuroleptic malignant-like syndrome and prolonged ICU stay.
Bonnici A; Ruiner CE; St-Laurent L; Hornstein D
Ann Pharmacother; 2010 Sep; 44(9):1504-7. PubMed ID: 20628041
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic malignant syndrome.
Goldwasser HD; Hooper JF
Am Fam Physician; 1988 Nov; 38(5):211-6. PubMed ID: 3189125
[TBL] [Abstract][Full Text] [Related]
10. Malignant syndrome in Parkinson's disease: concept and review of the literature.
Mizuno Y; Takubo H; Mizuta E; Kuno S
Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S3-9. PubMed ID: 12735909
[TBL] [Abstract][Full Text] [Related]
11. [A case of impending neuroleptic malignant syndrome associated with Shy-Drager syndrome].
Kumagai R; Harada T; Kurokawa K; Okazaki M; Egi N; Shimote K; Nakamura S
No To Shinkei; 1998 Aug; 50(8):745-9. PubMed ID: 9757468
[TBL] [Abstract][Full Text] [Related]
12. [Neuroleptic malignant-like syndrome following levodopa withdrawal].
Rascol O; Salachas F; Montastruc JL
Rev Neurol (Paris); 1990; 146(3):215-8. PubMed ID: 2184486
[TBL] [Abstract][Full Text] [Related]
13. Neuroleptic malignant syndrome in advanced Parkinson's disease.
Gordon PH; Frucht SJ
Mov Disord; 2001 Sep; 16(5):960-2. PubMed ID: 11746631
[TBL] [Abstract][Full Text] [Related]
14. Neuroleptic malignant syndrome. When levodopa withdrawal is the cause.
Rainer C; Scheinost NA; Lefeber EJ
Postgrad Med; 1991 Apr; 89(5):175-8, 180. PubMed ID: 2008397
[TBL] [Abstract][Full Text] [Related]
15. Neuroleptic malignant-like syndrome: case report.
Tibbels CK; Seegers S
Tex Med; 1988 May; 84(5):40-3. PubMed ID: 3406898
[No Abstract] [Full Text] [Related]
16. A hazardous side effect of neuroleptics: diagnosis and treatment.
Epperly TD; McGlaughlin VG; Leo KU
Geriatrics; 1990 Aug; 45(8):58-62. PubMed ID: 1974232
[TBL] [Abstract][Full Text] [Related]
17. [Neuroleptic malignant syndrome with clozapine monotherapy and benign hyperthermia after resolving neuroleptic malignant syndrome with clozapine. Two case reports].
Vetter P; Proppe D; Hoppe-Seyler S
Nervenarzt; 1991 Jan; 62(1):55-7. PubMed ID: 2027422
[No Abstract] [Full Text] [Related]
18. A neuroleptic malignantlike syndrome due to levodopa therapy withdrawal.
Friedman JH; Feinberg SS; Feldman RG
JAMA; 1985 Nov; 254(19):2792-5. PubMed ID: 4057489
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic malignant-like syndrome in an elderly patient caused by abrupt withdrawal of tolcapone, a-catechol-o-methyl transferase inhibitor.
Iwuagwu CU; Riley D; Bonoma RA
Am J Med; 2000 Apr; 108(6):517-8. PubMed ID: 10866587
[No Abstract] [Full Text] [Related]
20. Functional hyperthermia due to central dopaminergic impairment.
Di Rosa AE; Morgante L; Coraci MA; Crisafulli A; Cacciola G; Di Stefano G; Meduri M; Di Perri R
Funct Neurol; 1988; 3(2):211-5. PubMed ID: 2900182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
